72.10EUR-1.23%Mkt Cap: 902.17M $P/E: 14.451d ago
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region. It offer…
Industry Peers
Drug Manufacturers - Specialty & Generic$64.41BUSDP/E 23.3
$22.74BUSDP/E 19.8
$20.14BUSD
$17.18BUSDP/E 26.3
$15.40BUSDP/E 118.1
$14.51BUSDP/E 30.3
$12.90BUSD
$9.04BUSDP/E 23.0
$7.60BUSD
$7.11BUSDP/E 470.2
$7.00BUSDP/E 25.7
$5.70BUSDP/E 48.2
$3.69BUSDP/E 19.2
$3.57BUSDP/E 11.4
$3.01BUSDP/E 21.0
$2.79BUSD
$2.53BUSDP/E 56.2
$2.33BUSDP/E 16.1
$2.36BUSDP/E 12.8
$2.36BUSD
$1.90BUSDP/E 19.2
$1.97BUSD
$1.80BUSDP/E 20.3
$1.84BUSD
$1.74BUSD
$1.57BUSD
$1.48BUSDP/E 17.5
$1.52BUSDP/E 125.7
$1.35BUSDP/E 14.3
$1.21BUSDP/E 38.0
$1.17BUSDP/E 17.5
$1.16BUSD
$1.20BUSD
$1.07BUSDP/E Infinity
$1.01BUSD
$1.01BUSDP/E 197.0
$883.62MUSDP/E 38.6
$870.61MUSDP/E 11.9
$819.46MUSDP/E Infinity
$664.05MUSD
$702.13MUSDP/E 163.7
$635.41MUSDP/E 6.2
$503.88MUSDP/E 14.2
$516.92MUSD
$463.93MUSD
$437.60MUSD
$393.68MUSD
$377.35MUSD
$359.47MUSD
$339.22MUSD
$337.13MUSD
$319.75MUSDP/E 43.6
$351.79MUSD
$303.26MUSDP/E 9.7
$290.59MUSD
$267.31MUSDP/E 48.0
$280.94MUSDP/E 14.5
$250.29MUSDP/E 47.6
$246.73MUSDP/E 12.3
$233.72MUSDP/E 52.4
$207.94MUSDP/E 10.3
$202.91MUSD
$197.15MUSD
$187.92MUSDP/E 9.0
$175.54MUSD
$166.91MUSD
$143.51MUSDP/E 18.3
$132.34MUSD
$141.87MUSD
$128.15MUSD
$119.66MUSDP/E 18.6
$102.48MUSD
$85.39MUSDP/E 12.3
$93.61MUSD
$72.08MUSD
$65.22MUSD
$68.77MUSD
$63.45MUSDP/E 29.2
$60.45MUSDP/E 51.0
$64.05MUSD
$53.24MUSD
$52.01MUSD
$51.08MUSD
$49.45MUSD
$41.74MUSD
$46.21MUSD
$33.86MUSDP/E Infinity
$37.20MUSD
$31.62MUSD
$27.40MUSD
$24.18MUSD
$23.84MUSDP/E 206.0
$23.98MUSD
$23.08MUSD
$22.15MUSD
$18.78MUSD
$18.30MUSD
$14.93MUSD
$13.64MUSDP/E 16.6
$13.96MUSD
$11.82MUSD
$11.45MUSD
$9.96MUSD
$8.99MUSD
$8.21MUSD
$8.13MUSD
$6.51MUSDP/E 4.0
$6.35MUSD
$5.98MUSDP/E 0.2
$5.79MUSD
$5.46MUSDP/E Infinity
$3.29MUSDP/E 1.6
$1.93MUSD
$1.85MUSD
$1.85MUSDP/E 31.6
$1.54MUSD
$668.8KUSD
$173.7KUSDP/E 0.0
$175USD
Indicators:|
Key Statistics
Company
Market Cap902.17M $
Enterprise Value694.79M $
Revenue (TTM)571.40M $
Gross Profit426.98M $
Net Income (TTM)62.35M $
Revenue/Share49.17 USD
Last Price72.10 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees2.4K
CountryFR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINFR0004186856
Valuation
P/E (Trailing)14.45
P/E (Forward)12.88
PEG3.80
EV/EBITDA6.18
EV/Revenue1.22
P/S1.61
P/B1.51
EPS (TTM)4.94
EPS (Forward)5.64
52W Range
67.3020% of range91.50
52W High91.50 EUR
52W Low67.30 EUR
Profitability
Gross Margin74.73%
Oper. Margin16.82%
EBITDA Margin19.68%
Profit Margin10.91%
ROE9.70%
ROA7.51%
Growth
Revenue Growth-2.40%
Earnings Growth-5.10%
Cash Flow & Leverage
Operating CF78.34M $
CapEx (TTM)22.53M $
FCF Margin9.26%
FCF Yield5.86%
Net Debt-223.68M $
Net Debt/EBITDA-1.99
Balance Sheet
Debt/Equity0.03
Current Ratio3.08
Quick Ratio2.21
Book Value/Sh48.21 EUR
Cash/Share19.02 EUR
Dividends
Fwd Div Rate0.9300 EUR
Trail. Div Rate0.9300 EUR
Div. Yield1.28%
5Y Avg Yield0.88%
Payout Ratio18.02%
Ex-Div DateJun 3, 2026
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)90.38 EUR
Upside (mean)+25.3%
Target Range80.00 EUR – 110.00 EUR
€80.00+25.3% to mean€110.00
# Analysts4
Ownership
Shares Out.11.62M
Float3.65M
Insiders67.01%
Institutions13.23%
Technical
SMA 5071.30 (+1.1%)
SMA 20077.72 (-7.2%)
Beta0.89
S&P 52W Chg20.25%
Avg Vol (30d)7.04K
Avg Vol (10d)4.03K
Technical Indicators
RSI (14)52.1
MACD0.2650
MACD Signal0.0967
MACD Hist.+0.1683
BB Upper73.24 EUR
BB Middle71.72 EUR
BB Lower70.21 EUR
BB Width4.22%
ATR (14)1.369 EUR
Vol Ratio (20d)0.54x